Most Read Articles
05 Jul 2020
A recent study has assessed the long-term safety of nine systemic medications for psoriasis, revealing the lowest incidence of adverse events with ustekinumab and secukinumab.
Jairia Dela Cruz, 06 Jul 2020
Following vegan and vegetarian diets, which offer plenty of what is good for health, has been reported to have a downside: an increased risk of depression and anxiety, especially for younger adults.
Dr. Eliza Chakravarty, Dr. Brad Rovin, Dr. George Bersias, Dr. Andreas Schwarting, Dr. Andrea Doria, 4 days ago
A number of studies presented at the European League Against Rheumatism E-Congress 2020 (EULAR 2020) have a potential to impact the management of systemic lupus erythematosus (SLE) in the clinic. One phase II study showed that withdrawal of mycophenolate mofetil (MMF) may be safe in quiescent SLE, while a phase III trial demonstrated efficacy and tolerability of the B-lymphocyte stimulator (BLyS) inhibitor belimumab in SLE patients with lupus nephritis (LN). Experts also discussed how latest evidence on early intervention and disease activity assessment can be incorporated into clinical practice.
Tristan Manalac, 2 days ago
Infants born to mothers with the coronavirus disease 2019 (COVID-19) during the third trimester of pregnancy do not show altered cellular or humoral immunity, nor do they have unbalanced lymphocyte differentiation, according to a recent study.

HKU introduces latest robotic arm-assisted joint replacement technology in HK

Dr Margaret Shi
30 Jun 2020

The University of Hong Kong (HKU) is the first to introduce the latest Mako system for robotic arm-assisted total hip replacement (THR), partial knee replacement (PKR) and total knee replacement (TKR) in public hospitals in Hong Kong. Early experience from January 2019 to May 2020 shows improvement in surgical precision and early functional recovery with the new technology.

“Short-term results of robotic arm-assisted joint replacement surgery are encouraging, showing improved accuracy and safety of operation, a reduced need for revision operations, and greater patient satisfaction. Overall, the learning curve for experienced surgeons is not steep. Further studies are required to assess long-term patient outcomes and cost-effectiveness of the new technique,” said Dr Chun-Hoi Yan of the Department of Orthopaedics and Traumatology, HKU.

As of 22 May 2020, 161 cases of robotic arm-assisted joint replacement surgery had been performed, including 79 cases of TKR, 35 cases of PKR, and 47 cases of THR. All patients achieved good rehabilitation progress without major complications.

Robotic arm-assisted THR demonstrated greater accuracy in implant position (98 percent vs 80 percent) compared with conventional THR. Evidence of early functional recovery with successful straight knee raise within 24 hours was demonstrated in all patients who underwent robotic arm-assisted TKR, with 84 percent being discharged directly from hospital. Superior joint line restitution was achieved with robotic arm-assisted PKR.

Currently, there are three certified trainers of robotic arm-assisted joint replacement surgery in Hong Kong, who are responsible for training local and regional surgeons. “An experienced joint replacement surgeon will be able to acquire the skills needed to operate the robotic system with a learning curve of only 10 cases. PKR was found to have a shorter learning curve and can thus be used as an excellent teaching tool for young surgical trainees,” said Yan.

The latest Mako robotic arm surgical system, acquired with a charitable donation from Tam Shiu Charitable Trust, is the only US FDA-approved system for TKA, UKA and THA. The three-dimensional CT surgical planning enables accuracy and specificity for patients, while bone removal under haptic control ensures soft tissue protection. Sizing and positioning of implants are also controlled by the robotic system.

Approximately 500 joint replacement surgeries are performed at Queen Mary Hospital each year. According to the HKU experts, >200 patients with severe deformities, undertaking primary operation or at a younger age would be able to receive robotic arm-assisted joint replacement surgery.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Hong Kong digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
05 Jul 2020
A recent study has assessed the long-term safety of nine systemic medications for psoriasis, revealing the lowest incidence of adverse events with ustekinumab and secukinumab.
Jairia Dela Cruz, 06 Jul 2020
Following vegan and vegetarian diets, which offer plenty of what is good for health, has been reported to have a downside: an increased risk of depression and anxiety, especially for younger adults.
Dr. Eliza Chakravarty, Dr. Brad Rovin, Dr. George Bersias, Dr. Andreas Schwarting, Dr. Andrea Doria, 4 days ago
A number of studies presented at the European League Against Rheumatism E-Congress 2020 (EULAR 2020) have a potential to impact the management of systemic lupus erythematosus (SLE) in the clinic. One phase II study showed that withdrawal of mycophenolate mofetil (MMF) may be safe in quiescent SLE, while a phase III trial demonstrated efficacy and tolerability of the B-lymphocyte stimulator (BLyS) inhibitor belimumab in SLE patients with lupus nephritis (LN). Experts also discussed how latest evidence on early intervention and disease activity assessment can be incorporated into clinical practice.
Tristan Manalac, 2 days ago
Infants born to mothers with the coronavirus disease 2019 (COVID-19) during the third trimester of pregnancy do not show altered cellular or humoral immunity, nor do they have unbalanced lymphocyte differentiation, according to a recent study.